These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24767688)

  • 41. Time course and predictors of symptoms after primary prostate cancer therapy.
    Talcott JA; Manola J; Clark JA; Kaplan I; Beard CJ; Mitchell SP; Chen RC; O'Leary MP; Kantoff PW; D'Amico AV
    J Clin Oncol; 2003 Nov; 21(21):3979-86. PubMed ID: 14581420
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessing adverse events of postprostatectomy radiation therapy for prostate cancer: evaluation of outcomes in the Regione Emilia-Romagna, Italy.
    Showalter TN; Hegarty SE; Rabinowitz C; Maio V; Hyslop T; Dicker AP; Louis DZ
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):752-9. PubMed ID: 25752388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes.
    Boorjian SA; Eastham JA; Graefen M; Guillonneau B; Karnes RJ; Moul JW; Schaeffer EM; Stief C; Zorn KC
    Eur Urol; 2012 Apr; 61(4):664-75. PubMed ID: 22169079
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiotherapy after radical prostatectomy: Effect of timing of postprostatectomy radiation on functional outcomes.
    Huelster HL; Laviana AA; Joyce DD; Huang LC; Zhao Z; Koyama T; Hoffman KE; Conwill R; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg M; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Penson DF; Barocas DA
    Urol Oncol; 2020 Dec; 38(12):930.e23-930.e32. PubMed ID: 32736934
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prediction of erectile function following treatment for prostate cancer.
    Alemozaffar M; Regan MM; Cooperberg MR; Wei JT; Michalski JM; Sandler HM; Hembroff L; Sadetsky N; Saigal CS; Litwin MS; Klein E; Kibel AS; Hamstra DA; Pisters LL; Kuban DA; Kaplan ID; Wood DP; Ciezki J; Dunn RL; Carroll PR; Sanda MG
    JAMA; 2011 Sep; 306(11):1205-14. PubMed ID: 21934053
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional and oncological outcomes of patients aged <50 years treated with radical prostatectomy for localised prostate cancer in a European population.
    Becker A; Tennstedt P; Hansen J; Trinh QD; Kluth L; Atassi N; Schlomm T; Salomon G; Haese A; Budaeus L; Michl U; Heinzer H; Huland H; Graefen M; Steuber T
    BJU Int; 2014 Jul; 114(1):38-45. PubMed ID: 24053677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes in continence and erectile function between 2 and 4 years after radical prostatectomy.
    Glickman L; Godoy G; Lepor H
    J Urol; 2009 Feb; 181(2):731-5. PubMed ID: 19091349
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Health related quality of life outcomes after radical prostatectomy: attention to study design and the patient-based importance of single-surgeon studies.
    Dalkin BL; Christopher BA; Shawler D
    Urol Oncol; 2006; 24(1):28-32. PubMed ID: 16414489
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer.
    Wei JT; Dunn RL; Sandler HM; McLaughlin PW; Montie JE; Litwin MS; Nyquist L; Sanda MG
    J Clin Oncol; 2002 Jan; 20(2):557-66. PubMed ID: 11786586
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association between number of prostate biopsies and patient-reported functional outcomes after radical prostatectomy: implications for active surveillance protocols.
    Anderson CB; Tin AL; Sjoberg DD; Mulhall JP; Sandhu J; Touijer K; Laudone VP; Eastham JA; Scardino PT; Ehdaie B
    BJU Int; 2016 Jun; 117(6B):E46-51. PubMed ID: 26118438
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.
    Bradley EB; Bissonette EA; Theodorescu D
    BJU Int; 2004 Nov; 94(7):1003-9. PubMed ID: 15541117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy.
    Miller DC; Sanda MG; Dunn RL; Montie JE; Pimentel H; Sandler HM; McLaughlin WP; Wei JT
    J Clin Oncol; 2005 Apr; 23(12):2772-80. PubMed ID: 15837992
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How to optimize patient selection for robot-assisted radical prostatectomy: functional outcome analyses from a tertiary referral center.
    Gandaglia G; Suardi N; Gallina A; Zaffuto E; Cucchiara V; Vizziello D; Shariat S; Cantiello F; Damiano R; Guazzoni G; Montorsi F; Briganti A
    J Endourol; 2014 Jul; 28(7):792-800. PubMed ID: 24660774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radical perineal prostatectomy versus radical retropubic prostatectomy after previous prostate surgery: surgical and functional outcomes.
    Imperatore V; Cantiello F; Fusco F; Iannuzzo M; Di Meo S; Imbimbo C; Mirone V
    Urol Int; 2011; 86(2):140-5. PubMed ID: 21116105
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence and Predicting Factors for Commonly Neglected Sexual Side Effects to External-Beam Radiation Therapy for Prostate Cancer.
    Frey A; Pedersen C; Lindberg H; Bisbjerg R; Sønksen J; Fode M
    J Sex Med; 2017 Apr; 14(4):558-565. PubMed ID: 28258954
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Symptom indexes to assess outcomes of treatment for early prostate cancer.
    Clark JA; Talcott JA
    Med Care; 2001 Oct; 39(10):1118-30. PubMed ID: 11567174
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
    Donovan JL; Hamdy FC; Lane JA; Mason M; Metcalfe C; Walsh E; Blazeby JM; Peters TJ; Holding P; Bonnington S; Lennon T; Bradshaw L; Cooper D; Herbert P; Howson J; Jones A; Lyons N; Salter E; Thompson P; Tidball S; Blaikie J; Gray C; Bollina P; Catto J; Doble A; Doherty A; Gillatt D; Kockelbergh R; Kynaston H; Paul A; Powell P; Prescott S; Rosario DJ; Rowe E; Davis M; Turner EL; Martin RM; Neal DE;
    N Engl J Med; 2016 Oct; 375(15):1425-1437. PubMed ID: 27626365
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quality of life after radical prostatectomy or watchful waiting.
    Steineck G; Helgesen F; Adolfsson J; Dickman PW; Johansson JE; Norlén BJ; Holmberg L;
    N Engl J Med; 2002 Sep; 347(11):790-6. PubMed ID: 12226149
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Defining sexual outcomes after treatment for localized prostate carcinoma.
    Schover LR; Fouladi RT; Warneke CL; Neese L; Klein EA; Zippe C; Kupelian PA
    Cancer; 2002 Oct; 95(8):1773-85. PubMed ID: 12365027
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.